Evidence map›Paper›PMID 39285425›Full record

ArticleMalaria journal2024

Prospective acceptability of mass drug administration for malaria in Kedougou region in Senegal: a mixed method study.

Eva Legendre, Antoine Ndiaye, Ndèye Mareme Sougou, Jean Gaudart, El Hadj Ba, Valéry Ridde, Jordi Landier

Abstract read
In one paragraph

Article in Malaria journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eva LegendreAix Marseille Univ, IRD, INSERM, SESSTIM, ISSPAM, Marseille, France. eva.legendre25@hotmail.fr.
Antoine NdiayeInstitut de Santé et Développement, Université Cheikh Anta Diop, Dakar, Senegal.
Ndèye Mareme SougouInstitut de Santé et Développement, Université Cheikh Anta Diop, Dakar, Senegal.
Jean GaudartAix Marseille Univ, IRD, INSERM, SESSTIM, ISSPAM, AP-HM, La Timone Hospital, BioSTIC, Biostatistics and ICT, Marseille, France.
El Hadj BaInstitut de Recherche pour le Développement (IRD), Dakar, Sénégal.
Valéry Ridde *Institut de Santé et Développement, Université Cheikh Anta Diop, Dakar, Senegal.
Jordi Landier *Aix Marseille Univ, IRD, INSERM, SESSTIM, ISSPAM, Marseille, France.

Funding

Excellence Initiative of Aix-Marseille University - A*MIDEX, a French "Investissements d'Avenir" programme A*Midex International 2018French government under the France 2030 investment plan, as part of the Initiative d'Excellence d'Aix-Marseille Université - A*MIDEX - Institute of Public Health Sciences of Aix-Marseille AMX-20-IET-014
6 · The paper itself

Abstract

backgroundIn Senegalese high-burden regions, the existing package of interventions is insufficient to reach the malaria elimination goal. Asymptomatic carriers of Plasmodium contribute significantly to malaria persistence and are not targeted by current interventions. The systematic treatment of all individuals in a community (mass drug administration, MDA) is a relevant intervention to tackle asymptomatic infections. The intervention can only be effective with a high participation of the population and, therefore, depends largely on its acceptability. This study aims to investigate the prospective acceptability of MDA in the Kedougou region to inform its potential use in a future strategy.

methodsFollowing a 7-construct theoretical framework, prospective acceptability of MDA implemented in the rainy season was studied. In four villages, a sequential mixed design, from qualitative to quantitative, was used. In November 2021, interviews with healthcare professionals and focus groups with villagers were conducted. Findings from thematic analysis informed the development of a questionnaire administered to individuals aged ≥ 15 years in March 2022. Based on the questionnaire, an acceptability score was constructed and associations with socio-demographic factors were investigated using a linear mixed model.

resultsThe 7 interviews, the 12 focus groups, and the questionnaire administered to 289 individuals demonstrated a good acceptability of MDA. Two potential barriers were identified: the contradiction of taking a medication without feeling sick and the occurrence of side effects; and four facilitators: the perception of malaria as a burden, a good understanding of MDA, a good perceived effectiveness, and the resulting economic benefits. The average acceptability score was 3.5 (range from -7 to + 7). Young adults aged 15 to 21 had a lower acceptability score compared to the other age groups, indicating an additional barrier to acceptability (β = -0.78 [-1.67;0.1]).

conclusionMDA is a priori acceptable to communities of Kedougou region in Senegal. Sensitization campaigns co-constructed with the communities, especially targeting young adults, are essential to ensure good acceptability.

Indexed as

AntimalarialsMalariaMass Drug AdministrationAdolescentAdultAgedAsymptomatic InfectionsFemaleHumansMaleMiddle AgedPatient Acceptance of Health CareProspective StudiesSenegalYoung AdultAntimalarialsAsymptomatic malariaMass drug administrationMixed methodProspective acceptability

Identifiers

PMID39285425
PMCPMC11406725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.